With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...

Vektor Medical Receives FDA 510(k) Clearance Adding Atrial Flutter Mapping, Enhanced Connectivity and New Integration Capabilities to Next-Generation vMap Clearance Expands vMap’s Non-Invasive Mapping ...

The MarketWatch News Department was not involved in the creation of this content. Clearance Expands vMap's Non-Invasive Mapping Capabilities with Direct ECG Data Streaming, Software-Only Deployment ...

Boston Scientific announced that the FDA approved two navigation-enabled ablation catheters for treatment of type I atrial flutter. The magnetically tracked catheters (IntellaNav XP and IntellaNav ...

Vektor Medical, a medical technology company headquartered in San Diego redefining how arrhythmias are understood and treated, announced it has received the US Food and Drug Administration 510(k) ...

When your electrical system is working normally, the two upper chambers of the heart (atria) contract and pump blood into the two lower chambers (ventricles) in a well-coordinated way. This results in ...

Please provide your email address to receive an email when new articles are posted on . Dronedarone was associated with lower incidence of permanent atrial fibrillation/atrial flutter, more return to ...